Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits.
about
Wake-promoting pharmacotherapy for psychiatric disorders.Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury.Use of Stimulants in Bipolar Disorder.Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis.Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.Managing melancholic depression: a personal perspective.Addictive potential of novel treatments for refractory depression and anxiety.
P2860
Q34443394-D5FD66B4-F737-411E-AE37-401E71D8ABECQ36690676-93E4CE12-84E9-47F1-A461-917DF6B7F22DQ39112970-7CCAB910-5722-4AC4-9707-E33EE8477975Q39159752-88C624EF-A6CF-459F-8EC7-C2AFE95CDE01Q39427310-CB73C709-E7A4-45A2-9F55-03D89FD96EA9Q48049039-19D75CED-2847-42AD-8EE5-DE7AE36D29FBQ55334438-1F5FA88E-E30E-4D9D-97C5-3D2608525180
P2860
Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Psychostimulants for managing ...... m evaluation of cost benefits.
@en
Psychostimulants for managing ...... m evaluation of cost benefits.
@nl
type
label
Psychostimulants for managing ...... m evaluation of cost benefits.
@en
Psychostimulants for managing ...... m evaluation of cost benefits.
@nl
prefLabel
Psychostimulants for managing ...... m evaluation of cost benefits.
@en
Psychostimulants for managing ...... m evaluation of cost benefits.
@nl
P1476
Psychostimulants for managing ...... m evaluation of cost benefits.
@en
P2093
Georgia McClure
Heather Brotchie
P304
P356
10.1016/J.JAD.2013.05.093
P577
2013-06-27T00:00:00Z